- Consumer Products
- Latest 15.35
- Currency US$
- Change 0.08
- Percent Change 0.524 %
- Volume 1,090,406
- Wed Jul 30, 2014 04:00 PM EDT NASDAQ data delayed 15 minutes.
12 months ended Mar 31, 2014.
Trailing 12 month results shown above.
All data is in U.S. dollars.
|Earnings||Jul 30||$-0.23||Nov 3||$-0.24|
12 months ended Jul 31, 2014.
A look at major corporate events and financial announcements that are coming up.
About the Company
Keryx Biophamaceutical, Inc. uses data discovered through the mapping of the human genome to generate drug candidates that target the regulation of protein kinases. Protein kinases play a key role in the way cells communicate.